Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Medicis Pharmaceutical Corp. (NYSE: MRX)
OKLAHOMA CITY, OK--(Marketwire - October 8, 2008) - On October 3, 2008, a class action
lawsuit was filed in the United States District Court for the District of
Arizona against Medicis Pharmaceutical Corp. (NYSE: MRX). The complaint
alleges violations of federal securities laws, Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934 and Rule 10b-5, including allegations
of issuing a series of material misrepresentations to the market which had
the effect of artificially inflating the market price. The class period is
from October 30, 2003 through September 24, 2008.
Plaintiff seeks to recover damages on behalf of the Class. If you are a
member of the Class as described above, you may move the Court no later
than Tuesday, December 2, 2008, to serve as a lead plaintiff for the Class.
However, in order to do so, you must meet certain legal requirements
pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, participate in this or any other
lawsuit, or have any questions or concerns regarding this notice, or
preservation of your rights, please contact: